JNJ eyes Q2 growth with strong drug sales and new launches, but Stelara biosimilars and MedTech headwinds loom.
Johnson & Johnson (NYSE:JNJ) is set to report its earnings on Wednesday, July 16, 2025. For traders focused on events, analyzing historical stock behavior surrounding earnings reports can be an import
Financials make up half of the 38 S&P 500 companies slated to report quarterly results this week. The week's big economic news will be the consumer price index for June.
Time is one of investors' greatest allies. With enough patience, even a relatively small sum of money invested in an excellent company can yield substantial returns, especially when dividends are rein
Pre-Markets Red on Trump's Tariff Threats to Canada.
Microsoft, Broadcom, and Oracle were among the portfolio's top contributors for the quarter. Alternatively, Apple, Johnson & Johnson, and Berkshire Hathaway detracted from performance. Microsoft share
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Johnson & Johnson (JNJ), delve into some of its key metrics to gain a deeper insight into the company's potential performance fo
BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.
Dividend investing, like most things in life, can be rewarding if done correctly or a headache if you make crucial mistakes. The key to dividend investing is to pick the right types of dividend stocks
Johnson & Johnson JNJ will release earnings results for the second quarter, before the opening bell on Wednesday, July 16.

2 Dividend Stocks to Double Up on Right Now

03:10am, Friday, 11'th Jul 2025
No matter what the market is doing, one specific type of stock always will reward you -- and you don't have to lift a finger. This may sound too good to be true, but it actually isn't.
I analyze the 50 Fortune World's Most Admired Companies, focusing on dividend-paying stocks and their yield-based investment potential. Three companies—Pfizer, BMW, and Singapore Airlines—currentl
The majority of investors do not have hundreds of thousands of dollars to place into the stock market.
Johnson & Johnson JNJ is set to release its second-quarter earnings on Wednesday, July 16. According to Benzinga Pro data, analysts estimate adjusted earnings of $2.68 per share and sales of $22.85 bi
These dividend aristocrats haven't disappointed me in 15 years and won't disappoint you either.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE